Surgery Partners (SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies Joanna Gajuk - Bank of America A.J. Rice - UBS Andrew Mok - Barclays Tao Qiu - Stifel Sarah James - Cantor Fitzgerald Bill Sutherland - The Benchmark Company Benjamin Rossi - JPMorgan Will Spivack - TD Cowen Operator Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call.

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgery Partners (SGRY) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.28 per share a year ago.

Investors interested in stocks from the Medical Services sector have probably already heard of Surgery Partners (SGRY) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?

Surgery Partners, Inc. (NASDAQ: SGRY) will announce its first quarter 2024 results on Tuesday, May 7, 2024, before the market opens, followed by a conference call at 8:30 a.m. (Eastern Time).

Surgery Partners (SGRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The mean of analysts' price targets for Surgery Partners (SGRY) points to a 39% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

While the top- and bottom-line numbers for Surgery Partners (SGRY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Surgery Partners (SGRY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.27 per share a year ago.